Oppenheimer & CO Inc Bausch Health Companies Inc. Transaction History
Oppenheimer & CO Inc
- $6.18 Billion
- Q2 2024
A detailed history of Oppenheimer & CO Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 84,525 shares of BHC stock, worth $685,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
84,525Holding current value
$685,497% of portfolio
0.01%Shares
12 transactions
Others Institutions Holding BHC
# of Institutions
275Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$282 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$214 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$182 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$157 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$127 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.93B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...